Skip to main content
. 2011 Mar 14;13(3):465–469. doi: 10.1038/aja.2010.164

Table 3. ICSI and embryo transfer outcomes for HBV-positive and HBV-negative groups.

Variable Positive (n=325) Negative (n=325) P value
Age of wives (year) 31.4±4.3 31.5±4.3 NS
Female BMI (kg m−2) 22.1±2.9 22.1±3.2 NS
Duration of infertility (year) 4.9±3.1 5.0±3.3 NS
Times of IVF–ET/ICSI–ET (cycle) 1.2±0.5 1.3±0.6 NS
Primary infertility (n, %) 163 (50.1) 159 (48.9) NS
Distribution of infertile factors (n, %)      
 Total number of husbands with sperm problems 305 (93.8) 294 (90.5) NS
 Total number of wives with tubal blockage 163 (50.2) 177 (54.5) NS
 Total number of wives with ovulation failure 12 (3.7) 14 (4.3) NS
 Total number of wives with endometriosis 28 (8.6) 19 (5.8) NS
 Total number of couples with unexplained infertility 10 (3.1) 10 (3.1) NS
Duration of stimulation (day) 9.7±2.0 9.4±2.0 NS
Total dose of gonadotropin used (IU) 2572±1003 2570±1075 NS
Serum E2 levels on day of hCG injection (pmol l−1) 1 1509±7075 1 2212±7495 NS
No. of retrieved oocytes 13.1±6.9 12.8±6.5 NS
No. of embryos transferred in cycles by ET 2.3±0.5 2.3±0.6 NS
2PN fertilisation rate (%) 2445/3448 (70.9) 2463/3328 (74.0) 0.005
High-grade embryo rate (%) 1405/2439 (57.6) 1452/2403 (60.4) 0.046
Implantation rate (%) 126/688 (18.3) 159/657 (24.2) 0.008
Clinical pregnancy rate (%) 96/308 (31.2) 118/300 (39.3) 0.035
Cancellation rate (n, %) 17 (5.2) 25 (7.6) NS

Values are presented as mean±s.d.

Abbreviations: BMI, body mass index; E2, estradiol; ET, embryo transfer; HBV, hepatitis B virus; hCG, human chorionic gonadotrophin; ICSI, intracytoplasmic sperm injection; IVF, in vitro fertilisation; NS, not significant; 2PN, two-pronuclear.